Rebecca Fischer‐Betz

Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)

Hans‐Peter Tony, Gerd R Burmester, Hendrik Schulze‐Koops et al. · Arthritis Research & Therapy · 2011 · 208 citations · Full text

Life Sciences, Dermatology, Immunology +16

Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: Cross sectional analysis of the LuLa cohort

Anna Kernder, Jutta Richter, Rebecca Fischer‐Betz et al. · Lupus · 2021 · 108 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +16

EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update

Linda Rüegg, Andrea Pluma, Sabrina Hamroun et al. · Annals of the Rheumatic Diseases · 2025 · 107 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine

Rebecca Fischer‐Betz, Christof Specker, Ralph Brinks et al. · Lara D. Veeken · 2013 · 90 citations

Medicine, Immunology, Nephrology +13

Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) – results from a nationwide cohort in Germany (GRAID)

M. Witt, Mathias Grünke, Fabian Proft et al. · Lupus · 2013 · 87 citations

Life Sciences, Immunology, Internal Medicine +17